Research Topics
Species | P GarneroSummaryAffiliation: Synarc Inc Country: France Publications
| Collaborators
|
Detail Information
Publications
Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoringPatrick Garnero
INSERM Unit 664, Laennec School of Medicine, Lyon, France
Mol Diagn Ther 12:157-70. 2008..Thus, repeated measurements of bone markers during therapy may help improve the management of osteoporosis in patients...
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive proteinStephanie O Keeling
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
J Rheumatol 34:623-33. 2007..2) To assess the strength of recommendation for inclusion of individual criteria in the draft set...
Bone markers in osteoporosisPatrick Garnero
Synarc, 16 rue Montbrillant, 69003 Lyon, France
Curr Osteoporos Rep 7:84-90. 2009..This brief review discusses these novel technological developments and the recent clinical data on the use of established and new markers in postmenopausal osteoporosis...
Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of thPatrick Garnero
INSERM Unit 664, Lyon, France
Arthritis Rheum 62:33-43. 2010....
The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnoverAnne Christine Bay-Jensen
Department of Clinical Cell Biology, IRS CSFU, University of Southern Denmark, Vejle Hospital, Kabbeltoft 25, 7100 Vejle, Denmark
Arthritis Res Ther 11:R9. 2009..Here we investigate whether this response to oestrogen is also true for other type II collagen turnover markers known to be affected in osteoarthritis, and whether it relates to its presence in specific areas of cartilage tissue...
Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]Tim D Spector
Twin Research and Genetic Epidemiology Unit, St Thomas Hospital, London, UK
Arthritis Res Ther 7:R625-33. 2005..Both doses of risedronate were well tolerated. In this study, clear trends towards improvement were observed in both joint structure and symptoms in patients with primary knee OA treated with risedronate...
Identification of progressors in osteoarthritis by combining biochemical and MRI-based markersErik B Dam
Nordic Bioscience, Herlev Hovedgade 207, Herlev, Denmark
Arthritis Res Ther 11:R115. 2009..Specifically, we investigated aggregate cartilage longevity markers combining markers of breakdown, quantity, and quality...
Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohortPatrick Garnero
INSERM Unit 403 and Molecular Markers, Synarc, Lyon, France
J Rheumatol 32:697-703. 2005..To investigate the associations of molecular markers of joint tissue turnover with clinical and radiological variables in patients with hip osteoarthritis (OA)...
Biomarkers in osteoarthritisPatrick Garnero
INSERM Research Unit 403, Lyon, France
Curr Opin Rheumatol 15:641-6. 2003..Biologic markers reflecting quantitative and dynamic changes of joint tissue turnover represent promising adjunct tools...
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradationP Garnero
INSERM Unit 403, Hopital E Herriot, Lyon, France
J Bone Miner Res 18:859-67. 2003..We conclude that the generation of ICTP and CTX depends on different collagenolytic pathways. This finding may explain why these two markers may discriminate between different bone pathologies...
An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosisP Garnero
INSERM Research Unit 403, Hôpital E Herriot Pavillon F, 69437 Lyon Cedex 03, France
Bone 32:20-6. 2003..The test was a sensitive indicator of the antiresorptive effects of bisphosphonate and estrogens in postmenopausal women. This new bone resorption marker should be useful for the clinical investigation of patients with osteoporosis...
Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY studyP Garnero
Synarc 16 rue Montbrillant 69003, Lyon, France
Bone 40:716-22. 2007..The aim of this study was to investigate the associations between serum 25-hydroxyvitamin D (25-OH D), bone turnover markers, bone mineral density (BMD), radius bone loss and incidence of fracture in postmenopausal women...
Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA studyPatrick Garnero
INSERM Research Unit 403, and Synarc, Lyon, France
Arthritis Rheum 46:2847-56. 2002....
Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanerceptPatrick Garnero
INSERM Research Unit 664, Lyon, France
J Rheumatol 35:2313-5. 2008..Dickkopf-1 (Dkk-1) regulates bone remodeling in animal models of inflammatory arthritis, but its role in patients with rheumatoid arthritis (RA) remains unclear...
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trialPatrick Garnero
INSERM Research Unit 403 and Synarc, Lyon, France
Hum Reprod 17:2748-53. 2002....
Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritisP Garnero
INSERM Research Unit 403, Lyon, France
Ann Rheum Dis 62:939-43. 2003..To compare type II collagen degradation using a new urinary specific marker in patients with rapidly destructive and those with slowly progressive hip OA...
Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritisP Garnero
Molecular Markers, Synarc, Lyon, France
Ann Rheum Dis 65:1639-44. 2006..Aim: To investigate the association of rapidly destructive hip osteoarthritis with urinary Helix-II and urinary CTX-II...
Use of biochemical markers to study and follow patients with osteoarthritisPatrick Garnero
Synarc, Molecular Markers, Le Buroparc Bâtiment T4, 16 rue Montbrillant, 69003 Lyon, France
Curr Rheumatol Rep 8:37-44. 2006..Because osteoarthritis involves different tissues and complex biologic processes, a combination of different biochemical markers appears to be the most promising diagnostic strategy...
Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY studyPatrick Garnero
INSERM Research Unit 403, Hopital E Herriot, Lyon, France
J Bone Miner Res 18:1789-94. 2003..Seventy percent to 80% of women classified as having high bone turnover at baseline were similarly classified by the same methods 4 years later...
Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bonePatrick Garnero
INSERM Unit 403, Hopital E Herriot, Pav F, 69437 Lyon Cedex 03, France
Bone 38:300-9. 2006..We conclude that the extent and nature of collagen cross-linking contribute to the mechanical properties of fetal bovine cortical bone independently of bone mineral density...
Biochemical markers of joint tissue turnover in early rheumatoid arthritisP Garnero
University Hospital Maastricht, Maastricht, The Netherlands
Clin Exp Rheumatol 21:S54-8. 2003....
Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkersPatrick Garnero
INSERM Research Unit 403, Lyon, France
Curr Opin Rheumatol 16:428-34. 2004..More specific biologic markers reflecting systemic quantitative and dynamic changes of bone turnover represent promising adjunctive tools...
Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral densityP Garnero
Institut National de la Santé et de la Recherche Médicale Research Unit 403, Hopital E Herriot, Pavillon F, 69437 Lyon Cedex 03, France
J Clin Endocrinol Metab 90:4829-35. 2005..Vitamin D receptor (VDR) gene polymorphisms explain only a small part of the genetic influence on the level of bone mineral density (BMD), whereas their effect on fracture remains uncertain...
Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY studyPatrick Garnero
INSERM Research Unit 403, Synarc, Lyon, France
Arthritis Rheum 50:3137-44. 2004....
Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal womenP Garnero
INSERM Research Unit 403 and Synarc, Lyon, France
J Musculoskelet Neuronal Interact 4:50-63. 2004..Further studies in osteoporosis should explore the changes in these biochemical parameters of bone matrix as they may represent a key component of bone quality...
Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trialP Garnero
INSERM Research Unit 664, Lyon, France
Osteoarthritis Cartilage 16:660-6. 2008....
Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY studyP Garnero
INSERM Research Unit 403, Hopital E Herriot, Lyon, France
Bone 31:43-50. 2002..Larger long-term studies are necessary to assess adequately the relationships between IL-6 genotype, rate of bone loss, and risk of fracture...
Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosisPatrick Garnero
INSERM Unit 664, Synarc Lyon, 16 rue Montbrillant, Lyon, France
Clin Chem 54:188-96. 2008..We evaluated the performance of a fully automated assay for serum total N-terminal propeptide of type I collagen (P1NP), a marker of bone formation...
Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal womenP Garnero
INSERM U 403, Hopital E Herriot, Lyon, France
J Clin Endocrinol Metab 84:2390-7. 1999..The delayed decrease in bone formation observed with intranasal E2 compared to oral E2 may be related to different effects on serum IGF-I levels...
Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal studyP Garnero
Synarc, Lyon, France
Arthritis Rheum 52:2822-9. 2005....
Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritisPatrick Garnero
INSERM Unit 403, E Herriot Hospital and Synarc, Pavillon F, 69437 Lyon Cedex 03, France
Arthritis Rheum 46:2613-24. 2002....
Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosisP Garnero
INSERM Research Unit 403, Hopital E Herriot, Pavillon F, 69437 Lyon Cedex 03, France
Clin Chem 47:694-702. 2001..Our aim was to evaluate the technical and clinical performances of a new, fully automated assay for serum C-terminal cross-linking telopeptide of type I collagen (CTX), a marker of bone resorption...
The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of boneP Garnero
INSERM Unit 403, Hopital E Herriot, Pav F, 69003 Lyon, France
Bone 28:461-4. 2001..Measurement of type II collagen breakdown by a new urinary biochemical marker may be useful for in vivo assessment of the effects of drugs that potentially inhibit cartilage destruction...
Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damageP Garnero
INSERM Research Unit 403, Lyon, France
Ann Rheum Dis 60:619-26. 2001..The clinical performance of these two new markers was compared with that of a panel of other established biochemical markers of connective tissue metabolism...
Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritisPatrick Garnero
Synarc and Inserm Research Unit, Lyon, France
Arthritis Rheum 46:21-30. 2002....
Biochemical markers in osteoarthritis: will they measure up?Patrick Garnero
INSERM and Synarc Molecular Markers, Molecular Marker Division, Lyon, France
Nat Clin Pract Rheumatol 2:116-7. 2006
Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutationsPatrick Garnero
INSERM Research Unit 664, Lyon, France
Bone 44:461-6. 2009..Urinary alpha/betaCTX ratio has been proposed to reflect collagen maturation. We investigated changes in bone turnover and Col I isomerization in adult patients with OI and their relationship with Col I gene mutations...
Cross-sectional evaluation of bone metabolism in menP Szulc
INSERM Research Unit 403, Lyon, France
J Bone Miner Res 16:1642-50. 2001..After the age of 60 years, bone resorption markers--but not bone formation markers--increase in some men and are associated with lower BMD, suggesting that this imbalance is responsible for increasing bone loss in elderly men...
The collagenolytic activity of cathepsin K is unique among mammalian proteinasesP Garnero
INSERM Unit 403, Hopital E Herriot, Pav F, 69437 Lyon Cedex 03, France
J Biol Chem 273:32347-52. 1998..This property of cathepsin K is unique among mammalian proteinases and is reminiscent of bacterial collagenases. It is likely to be responsible for the key role of cathepsin K in bone resorption...
Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric studyP Chavassieux
, , Lyon, France
J Bone Miner Res 16:89-96. 2001..These effects on cortical bone were reflected by changes in biochemical markers. MDL markedly reduces bone turnover and increases BMD suggesting that this new agent may prevent postmenopausal bone loss...
Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown productsP Garnero
INSERM Unit 403, Department of Immunology, Hopital Edouard Herriot, Lyon, France
Bone 24:381-5. 1999..Bone formation appears to be reduced both in patients with and without joint destruction, whereas resorption is increased only in patients with joint destruction in relation to disease activity...
Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective studyP Garnero
INSERM Unit 403, Hopital E Herriot, Lyon, France
Osteoporos Int 8:563-9. 1998..If DXA is not available, the combination of history of fracture and urinary CTX performs as well as hip BMD to assess hip fracture risk in elderly women...
Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritisE Gineyts
INSERM Research Unit 403, Hopital Edouard Herriot, Pavillon F, Place d Arsonval, 69003 Lyon, France
Ann Rheum Dis 63:857-61. 2004....
Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitisD Vosse
Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
Rheumatology (Oxford) 47:1219-22. 2008....
Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradationE Gineyts
INSERM Research Unit 403, , Lyon and. SYNARC, Lyon, France
Rheumatology (Oxford) 40:315-23. 2001..CONCLUSION: Glc-Gal-PYD may be useful for the clinical investigation of patients with joint disease...
Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnoverE Gineyts
INSERM U403, Hopital E Herriot, Pavillon F, Place d Arsonval, 69437 Lyon Cedex 03, France
Biochem J 345:481-5. 2000....
Nitrated type III collagen as a biological marker of nitric oxide-mediated synovial tissue metabolism in osteoarthritisP Richardot
CCBR SYNARC, Lyon, France
Osteoarthritis Cartilage 17:1362-7. 2009..We investigated the nitration of type III collagen, a major constituent of synovial membrane, in knee OA...
Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritisRobert Landewe
Department of Internal Medicine Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
Arthritis Rheum 50:1390-9. 2004....
Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritisJ C Rousseau
INSERM Unit 403, Pavillon F, Hopital E Herriot, Lyon, France
Osteoarthritis Cartilage 12:440-7. 2004..In addition, we investigated circulating forms recognized by antiserum IIA in pools of serum from healthy adults, patients with OA and patients with RA...
Quantification of immature and mature collagen crosslinks by liquid chromatography-electrospray ionization mass spectrometry in connective tissuesE Gineyts
INSERM Research Unit 831 and Université de Lyon, Lyon, France
J Chromatogr B Analyt Technol Biomed Life Sci 878:1449-54. 2010..This novel technique should be useful to quantify simultaneously DHLNL, HLNL, PYD and DPD in connective tissues and to evaluate the maturation of collagen by determination of the ratio between immature and mature enzymatic crosslinks...
Cross-sectional and longitudinal assessment of pre- and postmenopausal bone loss with a portable forearm X-ray device: the Ofely studyF Duboeuf
INSERM Research Unit 403, Hopital E Herriot, Lyon, France
Bone 26:131-5. 2000....
Early effects of zoledronic acid and teriparatide on bone microarchitecture, remodeling and collagen crosslinks: comparison between iliac crest and lumbar vertebra in ewesN R Portero-Muzy
INSERM UMR 1033 et Université de Lyon, Lyon, France
Bone 51:714-9. 2012..The distinction of bone sites to study the early effects of anti-osteoporotic therapies appears meaningful in order to approach their site-specific anti-fracture efficacy...
A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnoverP Garnero
INSERM Unit 403, Hopital E Herriot, Lyon, France
Bone 24:603-9. 1999..Because this model is independent of the study design, it should be broadly applicable...
The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradationN Charni-Ben Tabassi
Synarc, Molecular Markers, Lyon, France
Osteoarthritis Cartilage 16:1183-91. 2008..In this study we analyzed the release of Helix-II and CTX-II from human cartilage collagen by the proteinases reported to play a role in cartilage degradation...
Increased Dickkopf-1 expression in breast cancer bone metastasesN Voorzanger-Rousselot
Molecular Markers, Synarc, Lyon F 69416, France
Br J Cancer 97:964-70. 2007..Measurements of circulating Dkk-1 levels may be useful for the clinical investigation of patients with breast cancer and bone metastases...
Potential contribution of IL-17-producing Th(1)cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditionsM Chabaud
Departments of Immunology and Rheumatology, , 69437 Lyon Cedex 03, France
Cytokine 13:113-8. 2001..As rheumatoid synovium is infiltrated by Th(1)cells, local cell interactions result in a pro-inflammatory pattern with defective repair, which can be reversed at least in part, by a Th(2)pattern...
The role of collagen in bone strengthS Viguet-Carrin
INSERM Research Unit 403 and Claude Bernard University, Lyon, France
Osteoporos Int 17:319-36. 2006..To illustrate the role of the crosslinking process of collagen in bone strength, clinical disorders associated with bone collagen abnormalities and bone fragility, such as osteogenesis imperfecta and osteoporosis, are described...
Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritisNadine Charni
Synarc, Lyon, France
Arthritis Rheum 52:1081-90. 2005..The HELIX-II ELISA should be useful for the clinical investigation of patients with arthritis and for identifying RA patients at higher risk of progression...
Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective studyPatrick Garnero
INSERM Unit 403, Hĵpital E. Herriot, Lyon, France
J Bone Miner Res 17:826-33. 2002..This suggests that alterations of type I collagen isomerization/racemization that can be detected by changes in urinary CTX ratios may be associated with increased skeletal fragility...
Monitoring individual response to hormone replacement therapy with bone markersP D Delmas
INSERM Research Unit 403, Hopital E Herriot, Lyon, France
Bone 26:553-60. 2000..Our data suggest that bone turnover markers can be used to monitor the BMD response to HRT at the individual level. Whether such monitoring could improve long-term compliance to HRT should be tested prospectively...
Biochemical markers of bone formation reflect endosteal bone loss in elderly men--MINOS studyP Szulc
INSERM 403 Research Unit, , Claude Bernard University, Lyon, France
Bone 36:13-21. 2005..In contrast, they do not reflect the periosteal bone formation, probably because the periosteal surface is smaller and has a slower remodelling rate than the endosteal surface...
Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterationsJean Charles Rousseau
INSERM Research Unit 831, Universite de Lyon, Lyon, France
Bone 46:897-900. 2010..We investigated whether cartilage degradation is altered in adult patients with mild osteogenesis imperfecta (OI) used as a human model of bone type I collagen-related osteoarthritis (OA)...
Short-term effects of new synthetic conjugated estrogens on biochemical markers of bone turnoverPatrick Garnero
INSERM Research Unit 403, Hĵpital E. Herriot, Lyon, France
J Clin Pharmacol 42:290-6. 2002..Synthetic conjugated estrogens significantly decreased bone resorption and bone formation comparable to that previously reported for estrogen treatments proven efficacious in preventing postmenopausal bone loss...
Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH studyPatrick Garnero
INSERM Research Unit 664, Lyon, France
J Bone Miner Res 23:1442-8. 2008..The influence of these biochemical changes of type I collagen on bone fracture resistance remains to be studied...
Biochemical markers in oncology. Part I: molecular basis. Part II: clinical usesN Voorzanger Rousselot
Molecular Markers, Synarc, 16 rue Montbrillant, Le Buroparc T4, Lyon Cedex 03, France
Cancer Treat Rev 33:230-83. 2007..A combination of different biochemical and imaging markers appears to be the most promising strategy to monitor patients with cancer...
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluationN Voorzanger Rousselot
Molecular Markers, Synarc, 16 rue Montbrillant, Le Buroparc T4, 69416 Lyon Cedex 03, France
Br J Cancer 95:506-14. 2006..Markers of bone resorption have the highest independent diagnostic value for detecting and potentially predicting BM in breast carcinoma patients...
The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destructionP P Geusens
University Hospital, Maastricht, The Netherlands
Arthritis Rheum 54:1772-7. 2006....
Markers of bone turnover in prostate cancerP Garnero
INSERM Research Unit 403 and Synarc, Lyon, France
Cancer Treat Rev 27:187-92; discussion 193-6. 2001..Thus, bone markers are likely to become a useful and objective tool to monitor bisphosphonate treatment and individual the therapy scheme...
Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY studyElisabeth Sornay-Rendu
INSERM Research Unit 403, Pavillon F, E. Herriot Hospital, 69437 Lyon Cedex 03, France
Bone 33:159-66. 2003....
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY studyP Garnero
INSERM Research Unit 1033, Lyon, France
Osteoporos Int 24:489-94. 2013....
The multiple facets of periostin in bone metabolismB Merle
INSERM Research Unit 1033, Pavillon F, Hopital E Herriot, Place d Arsonval, 69437, Lyon Cedex 03, France
Osteoporos Int 23:1199-212. 2012..The aim of this article is to provide an extensive review on the implications of periostin in bone biology and its potential use in benign and metabolic bone diseases...
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rhG Chevrel
Department of Immunology, , 69437 Lyon Cedex 03, France
Ann Rheum Dis 61:730-3. 2002..01). CONCLUSION: The effect of sTNFR on IL6, MIP-3alpha, and P1CP production by RA synoviocytes stimulated by activated PBMC supernatants was further enhanced when combined with sIL1R and sIL17R...
Markers of bone turnover for the management of patients with bone metastases from prostate cancerP Garnero
INSERM Research Unit 403, , Lyon, France
Br J Cancer 82:858-64. 2000..These findings suggest that these new resorption markers may be useful for the management of these patients...
Monitoring cartilage turnoverNadine Charni Ben Tabassi
Synarc, Le Buroparc Bâtiment T4, 16, rue Montbrillant, 69003 Lyon, France
Curr Rheumatol Rep 9:16-24. 2007....
Biological markers in osteoarthritisJ Ch Rousseau
INSERM Unit 1033 Pathophysiology, Diagnosis and Treatments of bone diseases, Universite de Lyon, Lyon, France
Bone 51:265-77. 2012..In this review, we will use the BIPED classification that appeared in 2006 for OA markers to describe the potential usage of a given marker [5]. This article is part of a Special Issue entitled "Osteoarthritis"...
[Prescription of bone remodeling markers in hospitals]J C Souberbielle
, 16, rue de Montbrillant, Le Buroparc T4, 69003 Lyon, France
Ann Biol Clin (Paris) 60:571-9. 2002..We propose that in a given hospital, the present article may serve as a basis for a discussion between clinicians and biologists about the development and/or the optimization of the measurements of these markers of bone turnover...
Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptideJean-Charles Rousseau
INSERM Unit 403, , Lyon, France
Methods Mol Med 101:25-37. 2004..0001) and 35% (p < 0.001), respectively, suggesting that type IIA collagen synthesis is altered in these arthritic diseases. The measurement of serum PIIANP may be useful for the clinical investigation of patients with joint diseases...
Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastasesNathalie Voorzanger-Rousselot
Biochemical Markers, Synarc, Lyon, France
Calcif Tissue Int 84:348-54. 2009..Measurements of circulating Dkk-1 with this new ELISA may be useful for the clinical investigation of patients with malignant bone diseases...
Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II studyM C Chapuy
Hopital Edouard Herriot, Lyon, France
Osteoporos Int 13:257-64. 2002....
Identification of osteopenic women at high risk of fracture: the OFELY studyElisabeth Sornay-Rendu
INSERM Research Unit 403, E Herriot Hospital, Lyon Cedex 03, France
J Bone Miner Res 20:1813-9. 2005..In the OFELY study, low BMD, increased markers of bone turnover, and prior fracture could be used to identify, within osteopenic women, those at high risk of fracture...
New automated multiplex assay for bone turnover markers in osteoporosisAurélie Claudon
CCBR SYNARC, Biochemical Markers, Lyon, France
Clin Chem 54:1554-63. 2008..We evaluated the performance characteristics of a novel, fully automated, protein-array chip system that allows the simultaneous measurement of CTX-I, PINP, OC, and intact parathyroid hormone (PTH) in 20 microL of serum...
Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiationUlrich Valcourt
INSERM Research Unit 403 and Université Lyon 1, Lyon, France
J Biol Chem 282:5691-703. 2007..We suggest that AGEs may play a role in the alterations of bone remodeling associated with aging and diabetes...
Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survivalJulia S Johansen
Department of Rheumatology, Herlev Hospital, Denmark
Clin Cancer Res 13:3244-9. 2007..In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment...
Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathyKarine Briot
Faculte de Medecine, Universite Paris Descartes, UPRES EA 4058, Hopital Cochin, Paris, France
J Rheumatol 35:310-4. 2008..We describe the effects of etanercept on biochemical markers of type II collagen synthesis and degradation in patients with SpA followed for 2 years...
Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdownChanghai Ding
Menzies Research Institute, University of Tasmania, Hobart, Australia
Osteoarthritis Cartilage 13:198-205. 2005..Furthermore, knee cartilage defects may result in increased cartilage breakdown leading to decreased cartilage volume and joint space narrowing suggesting an important role for knee cartilage defects in early knee OA...
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acidAllan Lipton
Department of Hematology Oncology, Milton S Hershey Medical Center, Pennsylvania State University, Hershey, PA 17033, USA
Cancer 113:193-201. 2008..For patients with bone metastases, high N-telopeptide of type I collagen (NTX) levels correlate with increased risks of skeletal-related events and death. However, the relation between NTX decreases and clinical benefits is unclear...
Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intakePierre J Meunier
Faculty of Medicine RTH, Laennec INSERM Unit 403, Rue G Paradin, 69372 Lyon Cedex 08, France
Osteoporos Int 16:1203-9. 2005..This could contribute to the repair of calcium deficiency and to the reduction of age-related bone loss in this population...
The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adultsPao Hwa Lin
Department of Medicine, Sarah W Stedman Center for Nutritional Studies, Duke University Medical Center, Durham, NC, USA
J Nutr 133:3130-6. 2003..A reduced sodium intake reduced calcium excretion in both diet groups and serum OC in the DASH group. The DASH diet and reduced sodium intake may have complementary, beneficial effects on bone health...
Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trialGuillaume Chevrel
Department of Rheumatology and Bone Diseases, Edouard Herriot Hospital, Lyon France
J Bone Miner Res 21:300-6. 2006..More studies are needed to evaluate an effect on the fracture rate...
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trialDouglas C Bauer
Department of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, California 94107, USA
J Bone Miner Res 21:292-9. 2006..The nonspine fracture efficacy of alendronate was significantly greater among both osteoporotic and nonosteoporotic women with higher baseline levels of the bone formation marker PINP...
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinomaKlaus Brasso
Department of Urology, H S Rigshospitalet, University of Copenhagen, Cophenhagen, Denmark
Prostate 66:503-13. 2006..To examine the prognostic value of markers of bone metabolism (serum PINP, BAP, and CTX-I) and serum YKL-40 in metastatic prostate carcinoma (PC)...
Serum leptin as a determinant of bone resorption in healthy postmenopausal womenChristian Roux
Centre d Evaluation des Maladies Osseuses, Departement de Rhumatologie, Hopital Cochin AP HP, Universite Rene Descartes, Paris, France
Bone 33:847-52. 2003..In conclusion, leptin may play a role as a determinant of bone resorption in healthy, untreated postmenopausal women, but the effect of estradiol or tibolone on bone are not mediated by leptin...
The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal womenStefan Arrenbrecht
R W Johnson Pharmaceutical Research Institute, Raritan, NJ, USA
Maturitas 48:197-207. 2004....
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trialDouglas C Bauer
Department of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, California 94105, USA
J Bone Miner Res 19:1250-8. 2004..In the alendronate group (n = 3105), greater reductions in one or more biochemical marker were associated with a lower risk of fracture...
Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosisChristian Roux
Groupe de Recherche et d Information sur les Ostéoporoses Task Force for Research and Information on Osteoporosis, Hopital Cochin, 27, rue du Faubourg St Jacques, 75014, Paris, France
Joint Bone Spine 72:26-31. 2005..Biochemical markers for bone turnover can be monitored after only 3-6 months provided steps are taken to control for intraindividual variability. They are useful when patient compliance is poor or the treatment response inadequate...
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosisDennis M Black
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94105, USA
N Engl J Med 349:1207-15. 2003..We conducted a randomized, double-blind clinical study of parathyroid hormone and alendronate to test the hypothesis that the concurrent administration of the two agents would increase bone density more than the use of either one alone...
Correlates of knee pain in younger subjectsGuangju Zhai
Menzies Research Institute, University of Tasmania, Hobart, Tasmania, 7001, Australia
Clin Rheumatol 26:75-80. 2007..MRI and biochemical measures can add to radiographs in defining unexplained knee pain in younger subjects...
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis stClifton O Bingham
Division of Rheumatology, Johns Hopkins University, 5200 Eastern Avenue, Mason F Lord Building, Center Tower, Room 404, Baltimore, MD 21224, USA
Arthritis Rheum 54:3494-507. 2006....
Fractures and handicap in an adult population: A clinical studyGuillaume Chevrel
Medicine Department, Valence Hospital, 179 boulevard Marechal Juin, 26000 Valence Cedex 09, France
Joint Bone Spine 74:584-9. 2007..To evaluate the bone status of ambulatory patients with physical and mental handicaps before a program of fracture prevention...
Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly womenKaisa K Ivaska
Clinical and Molecular Osteoporosis Research Unit, Department of Orthopaedics, Lund University, Malmo University Hospital, Malmo, Sweden
J Bone Miner Res 22:1155-64. 2007..Markers were not altered in the immediate postfracture period but were clearly elevated during fracture repair. Recent fracture should thus be taken into account when markers are used in clinical practice...
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trialsWalter P Maksymowych
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
J Rheumatol 34:634-40. 2007..Our objective was to develop validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting radiological endpoints in RA and SpA clinical trials...
